Skip to main content
Boryung Corporation logo

Boryung Corporation — Investor Relations & Filings

Ticker · 003850 ISIN · KR7003850005 KO Manufacturing
Filings indexed 354 across all filing types
Latest filing 2019-10-28 Earnings Release
Country KR South Korea
Listing KO 003850

About Boryung Corporation

https://pharm.boryung.co.kr/eng/index.do

Boryung Corporation is a fully integrated healthcare company founded in 1957. Its core business encompasses the research, development, manufacturing, and global commercialization of pharmaceutical products, with a significant presence in the cardiovascular therapeutic area. The company is distinguished by its pioneering 'Care in Space' (CIS) initiative, which focuses on developing healthcare solutions for humans in extreme environments and leveraging space for new research opportunities. In addition to its pharmaceutical operations, Boryung functions as a healthcare investment company, fostering innovation across the health sector. The company's diverse portfolio includes prescription drugs, over-the-counter products, and a pipeline aimed at addressing future medical needs.

Recent filings

Filing Released Lang Actions
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Boryung Pharmaceutical. It provides key financial highlights such as revenue, operating profit, and net income for the third quarter of 2019. It is a short, summary-style announcement of financial results, which fits the definition of an Earnings Release (ER). Q3 2019
2019-10-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, specifically regarding pledge agreements and shareholding status of major shareholders (Boryung Holdings and related parties). This falls under the category of Major Shareholding Notification (MRQ).
2019-10-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the shareholding changes of an individual executive (Lee Min-ho) at Boryung Pharmaceutical Co., Ltd., specifically reporting a 'disposal in the market' (장내매도) of 4,000 shares. This type of filing is a standard disclosure for insider trading/director dealings.
2019-09-26 Korean
단일판매ㆍ공급계약해지
Regulatory Filings Classification · 95% confidence The document is a formal regulatory disclosure from Boryung Pharmaceutical regarding the termination of a supply and licensing contract. It details the contract value, the counterparty (Sandoz AG), the reason for termination, and the financial impact. Since this is a specific regulatory announcement regarding a material contract event that does not fit into categories like M&A, dividends, or share transactions, it is classified as a general regulatory filing.
2019-08-26 Korean
반기보고서 (2019.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Boryung Pharmaceutical Co., Ltd., covering the period from January 1, 2019, to June 30, 2019. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2019
2019-08-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (specifically '장내매수' or on-market purchase) of an executive (Shin Sang-su) of Boryung Pharmaceutical. This type of filing is a standard disclosure for insider trading/director dealings under Korean financial regulations.
2019-08-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.